Clinical Trial Update: Safety and Immunogenicity of a New Inactivated Poliovirus Vaccine in Infants [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updates indicate safety and immunogenicity of a new inactivated poliovirus vaccine in infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Investigational inactivated poliovirus vaccine

Snippet

Sponsor: Pauline Verdijk | Conditions: Poliomyelitis | Phase 1, Phase 2 | Status: COMPLETED